Version June 2024
| Multivariate Cox model and the points assigned to each category of prognostic factors in the new prognostic score system | ||
| Characteristics | Point | |
| Patient characteristics | ||
| Ascites | Yes | 2 |
| No | 0 | |
| Abdominal pain | Yes | 2 |
| No | 0 | |
| Weight loss | Yes | 2 |
| No | 0 | |
| Child-Pugh grade | C | 5 |
| B | 2 | |
| A | 0 | |
| Biochemistry | ||
| Serum alkaline phosphatase (ALP), int. unit/L | >200 | 3 |
| ≤200 | 0 | |
| Total bilirubin | >50 int. unit/L (2.9 mg/dL) | 3 |
| >33 to ≤50 int. unit/L (1.9 mg/dL to 2.9 mg/dL) | 1 | |
| ≤33 int unit/L (1.9 mg/dL) | 0 | |
| Urea | >8.9 mmol/L (>25 mg/dL) | 2 |
| ≤8.9 mmol/L (≤25 mg/dL) | 0 | |
| Tumor characteristics | ||
| Portal vein thrombosis | Yes | 3 |
| No | 0 | |
| Tumor size | Diffuse | 4 |
| >5 cm | 3 | |
| ≤5 cm | 0 | |
| Lung metastases | Yes | 3 |
| No | 0 | |
| Serum alpha-fetoprotein (AFP), ng/mL | >400 | 4 |
| ≤400 | 0 | |
| Probability of patients surviving at least 3 months estimated by the advanced liver cancer prognostic system score | ||
| Prognosis | Score | 3-month survival rate, % |
| Good | 0 to 2 | >81 |
| 3 to 6 | 72 to 80 | |
| 7 to 8 | 66 to 69 | |
| Intermediate | 9 | 63 |
| 10 to 12 | 51 to 59 | |
| 13 to14 | 42 to 7 | |
| 15 | 38 | |
| Poor | 16 | 33 |
| 17 to 19 | 21 to 29 | |
| 20 to 22 | 10 to 17 | |
| ≥23 | <10 | |
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟
